M
Mile High Labs
End-to-end GMP certified manufacturer of premium CBD crude oil, distillate, and isolate
About Mile High Labs
Mile High Labs is a prominent player in the cannabinoid industry, focusing on the manufacturing, testing, and distribution of cannabinoid products. The company serves a diverse range of clients, including consumer packaged goods companies, beverage manufacturers, and health and wellness brands. Operating in the global cannabinoid market, Mile High Labs leverages its expertise in cannabinoid science and technology to offer innovative solutions such as water-soluble CBD isolates, which are ideal for CBD-infused beverages. The business model revolves around producing high-quality cannabinoid products and providing comprehensive testing services to ensure product safety and efficacy. Revenue is generated through the sale of cannabinoid products and testing services. Mile High Labs is dedicated to advancing the global cannabinoid industry through its commitment to excellence and innovation.
Source: Dealroom company dataKnowledge graph
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Dec 2023 | $23M | $325M | Undisclosed | ↗ |
| SERIES BOther financing | Aug 2020 | — | — | John Paul DeJoria | — |
Growth signals
Latest recorded traffic for Mile High Labs is 9.2K monthly website visits, up 95.7% over the last three months. Mile High Labs's team grew 1.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Mile High Labs in the Loveland ecosystem
The Mile High Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
John Paul DeJoria
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mile High Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mile High Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







